BCRX 🟢 BioCryst Pharmaceuticals Inc is trading 6.46% up in pre-market BioCryst Pharmaceuticals Inc July 14, 2026 BCRX is trading at $10.55, up 6.46% in pre-market. Open in OpenBell More BCRX News Related News BCRX November 05, 2026 🔴 BioCryst Pharmaceuticals is trading 8% down today amid broad market and biotech selling BCRX November 04, 2026 🔴 BioCryst Pharmaceuticals is trading 5% down today as licensing and international orders drove revenue outlook BCRX November 04, 2026 BioCryst Pharmaceuticals' third quarter 2026 revenue beat estimates and total FY 2026 guidance was raised BCRX November 03, 2026 BioCryst Pharmaceuticals Inc Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026 BCRX October 22, 2026 BioCryst Wins FDA Approval for ORLADEYO Pellets for HAE Patients 12+
